✨ Free AI Report
Raphael Pharmaceutical Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Raphael Pharmaceutical Inc.
Research Preview

Raphael Pharmaceutical Inc.: Business Overview, Financials & Competitive Analysis

Raphael Pharmaceutical Inc. is a pharmaceutical drug research and development company focused on the discovery and clinical development of life-improving drug therapies based on cannabinoids. The company is a clinical...

Analyst-debate audio for Raphael Pharmaceutical Inc.

AskCyborg analysts argue the bull and bear cases for Raphael Pharmaceutical Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Raphael Pharmaceutical Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
4/ 10Mixed

Cyborg Score thesis

Early-stage cannabinoid-based biotech with differentiated immunology focus, but faces liquidity pressures and requires successful...

Read the full analyst-debate transcript →
Industry Cannabinoid-based therapeutics
4 named competitors
2 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: June 22, 2026
AI-Verified Research
30+ Page Report

Get the Latest Raphael Pharmaceutical Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Raphael Pharmaceutical Inc. Overview

Pro stress-test →

Raphael Pharmaceutical Inc. is a pharmaceutical drug research and development company focused on the discovery and clinical development of life-improving drug therapies based on cannabinoids. The company is a clinical-stage biotechnology company in the healthcare sector focused on the development of cannabinoid-based therapies.

Strategic Profile

Pro stress-test →

The company is advancing a novel research platform built on highly purified cannabinoids that are free of THC and CBD, with an emphasis on inflammatory and autoimmune diseases. The company develops a lead product candidate for the treatment of rheumatoid arthritis and intends to develop cannabinoid-based drug products for the treatment of oncology indications and other autoimmune diseases.

Competitive Landscape

Pro stress-test →

Raphael competes in the emerging cannabinoid-based therapeutics space against larger biotech firms exploring endocannabinoid modulation (e.g., companies targeting CB2 receptors), conventional small-molecule immunosuppressants for RA (Regeneron, AbbVie biologics), and oncology checkpoint inhibitors. Differentiation derives from proprietary purified cannabinoid platform and focus on immune-inflammatory pathways rather than psychoactive effects.

Industry Context

Raphael Pharmaceutical Inc. operates in Cannabinoid-based therapeutics.

Key facts

Founded: 2021 · Headquarters: Jaffa, Israel · Employees: N/A · Revenue: N/A · Market cap: N/A

What the analysts stress-tested

The top findings that survived the multi-agent debate for Raphael Pharmaceutical Inc..

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Raphael Pharmaceutical Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

RinvoqJAK inhibitor for rheumatoid arthritis→KevzaraIL-6 antagonist for RA→OpdivoPD-1 inhibitor for oncology indications→GWP42006Cannabinoid-based therapeutic development→

Compare Raphael Pharmaceutical Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Raphael Pharmaceutical Inc. operates in Cannabinoid-based therapeutics. See how the rest of the sector scores on the Cyborg framework.

Browse Cannabinoid-based therapeutics research →
NEW · MCP server

Ask your AI assistant about Raphael Pharmaceutical Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Raphael Pharmaceutical Inc. and its top competitor on Cyborg Score”
“What did Raphael Pharmaceutical Inc. do this quarter?”
“Is Raphael Pharmaceutical Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Raphael Pharmaceutical Inc. do?+
Raphael Pharmaceutical Inc. is a pharmaceutical drug research and development company focused on the discovery and clinical development of life-improving drug therapies based on cannabinoids. The company is a clinical...
What is Raphael Pharmaceutical Inc.'s Cyborg Score?+
Raphael Pharmaceutical Inc. has a Cyborg Score of 4/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Raphael Pharmaceutical Inc.'s main competitors?+
Named competitors include Rinvoq, Kevzara, Opdivo, GWP42006. The full competitive landscape is in the AskCyborg report.
How can I get the full Raphael Pharmaceutical Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Raphael Pharmaceutical Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Raphael Pharmaceutical Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

Other strong performers across the analyst-debate framework. Click any to see their research report.

9Sezzle Inc.9Carpenter Technology Corporation9Credo Technology Group Holding Ltd9TE Connectivity plc9Rheinmetall AG9Northrop Grumman Corporation9Interactive Brokers Group, Inc.9Berkshire Hathaway Inc.9Mastercard Incorporated8Vera Therapeutics, Inc.8Quoin Pharmaceuticals, Ltd.8Prenetics Global Limited8Strattec Security Corporation8Lesaka Technologies Inc.8Abu Dhabi Ship Building PJSC8Judges Scientific plc8Weathernews Inc.8Orrstown Financial Services, Inc.